🇺🇸 FDA
Patent

US 10472386

Bile acid derivatives as FXR agonists and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 10472386 (Bile acid derivatives as FXR agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00